Outcomes4Me is a founding member of CancerX, an initiative of the Cancer Moonshot Learn more >

/ Suzanne Garner, Director of Marketing & Community, Outcomes4Me
In recent years, an empowering, encouraging shift is taking place in breast cancer research and...
The American Society of Clinical Oncology (ASCO) hosts an annual conference where more than 40,000...
A breast cancer diagnosis is undeniably challenging. The arsenal of treatments that are recommended to...
We’re excited to announce that Outcomes4Me now includes non-small cell lung cancer (NSCLC) as a...
The Women’s Health and Cancer Rights Act of 1998 entitles individuals who have undergone a...
For many breast cancer patients, undergoing a lumpectomy or mastectomy is a life-altering event that...
A core decision almost all breast cancer patients must make is which type of breast...
Breast cancer is a complex experience that affects millions of people worldwide. As a patient...
CDK 4/6 inhibitors have received a lot of attention in the past few weeks for...
Endocrine therapy for early-stage HR+ breast cancer is witnessing significant advancements and moving away from...